Berlin (ots/PRNewswire) - - 'Vaccination apathy' is a key barrier to protecting the community against infectious disease, according to global health experts - By 2060, 30% of Europeans will be aged 65 years or over[1] - a life-course approach to immunisation, including adult vaccination, is a cost-effective method ...
New York, July 6, 2010 (ots/PRNewswire) - Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, ...
Rome, June 8, 2010 (ots/PRNewswire) - UK Premiership footballer Rory Delap, renowned for his devastating throw-in, has joined forces with a number of football heroes across Europe to support 'Back in Play', a European wide campaign to reach young men and women and raise awareness of ankylosing spondylitis (AS), a poorly understood condition which can affect the lower back. To view the Multimedia News Release, ...
London (ots/PRNewswire) - - Not for UK Journalists - New Survey Reveals Widespread Ignorance of Debilitating Pain Condition Affecting Millions of Europeans Alarmingly, nearly sixty per cent of Europeans have never heard of neuropathic pain (NeP), (1) a debilitating nerve condition that affects approximately 22 million people, (2),(3) according to ...
New York (ots/PRNewswire) - Pfizer Inc said today that a Danish court has granted a preliminary injunction against Nomeco A/S -- the largest pharmaceutical wholesaler in Denmark -- that prohibits the sale of a generic version of Lipitor by generics manufacturer Ranbaxy. The injunction, issued by the Bailiff's Court of the Copenhagen City Court in Denmark and ...
New York (ots/PRNewswire) - - Celebrex to be Available in Europe for the Treatment of Ankylosing Spondylitis, a Debilitating Form of Arthritis Pfizer Inc announced today that 17 European countries agreed to extend the Celebrex (celecoxib capsules) label to include symptomatic relief in the treatment of ankylosing spondylitis (in adults), a form of arthritis that affects the spine. Once each country updates ...
New York (ots/PRNewswire) - - If Approved, Maraviroc will be the First in a New Class of Medications Available for HIV Treatment Pfizer announced today that marketing authorization applications for maraviroc will receive accelerated review in both the United States and Europe. Accelerated reviews are granted to potential medicines that, if approved, would ...
New York (ots/PRNewswire) - - Full marketing authorization and extension of indication to first-line treatment of advanced and/or metastatic renal cell carcinoma (MRCC) - First multiple receptor tyrosine kinase inhibitor to be approved in the EU for first-line use in MRCC Pfizer Inc said today that ...
New York (ots/PRNewswire) - - Broad Access Program for Patients with Limited Available Treatment Options Pfizer announced today that it plans to establish a multi-national Expanded Access Program (EAP) to make the investigational CCR5 antagonist maraviroc, currently in ongoing phase 3 clinical ...
Las Vegas, November 15 (ots/PRNewswire) - - New data confirm a five-year risk assessment tool will help ophthalmologists better predict which patients have an increased risk of developing glaucoma - Analysis finds that patients with elevated intraocular pressure (IOP) - along with other ...
New York (ots/PRNewswire) - - Madrid, Spain Court of Appeal Confirms Pfizer's Patent Claims Pfizer Inc said today that the European Patent Office (EPO) has issued an opinion upholding, in its entirety, the company's calcium salt patent covering Lipitor. The opinion was provided at the request of a Spanish court that is hearing a patent infringement case filed against Pfizer by generic manufacturer Ranbaxy. ...
New York (ots/PRNewswire) - - Company Opens its Compound Library to Help Search for New Anti-Parasitic Medicines Pfizer announced today collaboration that gives access to its library of medicinal compounds -- the world's largest -- and also brings scientists from developing countries into ...
New York (ots/PRNewswire) - Pfizer said today that the Austrian Patent Office has ruled that a claim in the company's basic patent covering the use of atorvastatin, the active ingredient in Lipitor, would be infringed by generic manufacturer Ranbaxy. Ranbaxy can appeal the ruling, but the patent will remain ...
New York (ots/PRNewswire) - - Lyrica's neuropathic pain indication broadened to include central nerve pain; Central nerve pain is associated with conditions such as spinal cord injury, stroke, and multiple sclerosis - A robust and unprecedented clinical program involving more than 10,000 patients supports Lyrica's efficacy and safety in ...
Copenhagen, Denmark (ots/PRNewswire) - - Twice as Many People With Uncontrolled Type 2 Diabetes Would Accept Insulin if Offered Exubera, Even in Countries Where Pens are Commonly Used, Additional Study Shows - Patients With Diabetes Gained Less Weight With Exubera Than With Injectable ...
New York (ots/PRNewswire) - - WSJ/Professor Pedro Nueno: "The drug could encourage diabetes sufferers to get treatment earlier and more often. This has such a tremendous advantage for a huge number of people worldwide. It is a real breakthrough." - PharmaBarometer: "Despite only being launched into the German market in May 2006, it has been immediately ...
New York (ots/PRNewswire) - - Heart Disease Patients who Were at a Very High Risk for Having a Second Heart Attack and Took Lipitor 80mg Had a 46 Percent Reduction in the Risk of Experiencing Additional Heart Attacks Compared With Patients Taking Simvastatin - Investigator: 'These data suggest the benefit ...
New York (ots/PRNewswire) - - Lipitor Reduces Risk of Major Cardiovascular Events Such as Heart Attacks in People With Heart Disease and With a Cluster of Other Major Cardiovascular Risk Factors, Often Referred to as Metabolic Syndrome, New Analysis Shows - Heart Disease Patients With Metabolic Syndrome who Took Lipitor 80mg Dose Reduced Their Risk of Major Cardiovascular Events by Nearly 30 ...
New York (ots/PRNewswire) - - More Than 1.2 Million Europeans Die of Smoking-Related Diseases Each Year; An Estimated US$500 Billion in Global Health-Related Costs by 2010 - Medical Expert: 'Helping smokers quit is one of the most important things a physician can do to improve their patients' overall health and reduce the risk of developing serious ...
Geneva (ots-prnewswire) - Pfizer Inc Announces Launch of Survey in Multiple Countries to Document the Impact of Sexual Health in the Second Half of Life Problems with sexual health are a legitimate health concern according to nearly 70 percent of men and women age 40+ in a five-country survey(A) funded by ...